Form 4: KALA BIO Chief Business Officer Sells Shares to Cover Tax Obligations
Insider Transaction Report
KALA BIO's Chief Business Officer, Darius Kharabi, sold 730 shares of common stock on June 3, 2025, to satisfy tax withholding obligations related to restricted stock unit vesting.
Summary
- Darius Kharabi, Chief Business Officer of KALA BIO, Inc. (KALA), reported a transaction on June 3, 2025.
- He sold 730 shares of KALA BIO Common Stock at a weighted average price of $3.74 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021.
- The purpose of the sale was to cover tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs) granted on May 31, 2023.
- Following this transaction, Mr. Kharabi beneficially owns 67,077 shares of KALA BIO common stock, which includes 41,159 unvested RSUs.
Sentiment
Score: 5
Explanation: The transaction is a routine sale to cover tax obligations from RSU vesting, which is a common and non-discretionary event for executives. It does not indicate a change in management's outlook on the company.
Future Outlook
NA
Management Comments
- This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on May 31, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.05, inclusive.
- The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 2021-11-16 | Date Reporting Person adopted the 10b5-1 trading plan. |
| 2023-05-31 | Date restricted stock units (RSUs) were granted to the Reporting Person. |
| 2025-06-03 | Date of the reported transaction (sale of common stock). |
| 2025-06-04 | Date the Form 4 was signed by Attorney-in-Fact. |
Keywords
KALA BIO, KALA, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Darius Kharabi, Chief Business Officer, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.